Stem cell research is still too hot for most investors, but NeoStem is starting to change that, thanks to some unexpected events. Among them are the Catholic Church’s surprising embrace of NeoStem’s research and NeoStem’s foothold in China’s vast health care market.
Continue reading Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican’s Backing
Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican’s Backing originally appeared on DailyFinance on Mon, 07 Mar 2011 07:30:00.
Filed Under: Company News, Technology, Columns, Investing, Health Care, Stock Picks